Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes

American Journal of Perinatology

Volumn 15, Issue 8, 1998, Pages 479-486

  Bellart, Jordi ^a   Gilabert, Rosa ^b   Fontcuberta, Jordi ^c   Carreras, Elena ^d   Miralles, Ramón M ^a   Cabero, Lluis ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Coagulation; Diabetes; Fibrinolysis; Pregnancy

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031753878     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994069     Document Type: Article

References (32)

1. Cerqueira MJ, Cabero L. Diabetes y gestación. In Cabero L (eds): Riesgo Elevado Obstetrico. Barcelona: Masson; 1996: pp 169-197
2. Spellacy WN, Goetz FC. Plasma insulin in normal late pregnancy. N Engl J Med 1963;268:988-991
3. Kühl C, Holst JJ. Plasma glucagon and insulin: Glucagon ratio in gestational diabetes. Diabetes 1976;25:16-23
4. Andersen O, Kühl C, Buch I. Insulin receptors in normal pregnant women and women with gestational diabetes. Acta Endocrinol 1986;277:27-30
5. O'Sullivan JB, Hurwitz D. Spontaneous remissions in early diabetes. Arch Intern Med 1966;117:769-774
6. Freinkel N, Metzger BE, Phelps RL, Dooley SL, Ogama ES, Radvany RM, Belton A. Gestational diabetes mellitus. Heterogenity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring Diabetes 1985;34(Suppl 2):1-7
7. Mestman JH, Anderson GV, Guadalupe V. Follow-up study of 369 subjects with abnormal carbohydrate metabolism during pregnancy. Obstet Gynecol 1972;39:421-425
8. Mestman JH. Follow-up studies in women with gestational diabetes mellitus. In Weiss DA, Coustan DR (eds): Gestational Diabetes. New York: Springer-Verlag; 1987: pp 191-198
9. Carmassi F, Morale M, Puccetti R, De Negri F, Monzani F, Navalesi R, Mariani G. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 1992;67:643-654
10. España F, Gilabert J, Vicente V, Estelles A, Vazquez L, Hendl S, Aznar J. Activated protein C: Alpha 1 antitrypsin complex as a marker for in vitro diagnosis of prethrombotic states. Thromb Res 1992;66:499-508
11. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T. Activation of tissue factor-induced coagulation and endothehal cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler. Thromb Vasc Biol 1995;15:1114-1120
12. Petersen KR, Skouby SO, Jespersen J. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud 1995;40:105-111
13. Small M, Douglas JT, Lowe GDO, MacCuish AC, Forbes CD. Effect of insulin therapy on coagulation and platelet function in type II diabetes mellitus. Haemostasia 1986; 16:417-423
14. Sobrevia L, Cesare P, Yudilevich DL, Mann GE. Diabetes-induced activation of system y+ and nitric oxide synthase in human endothelial cells: Association with membrane hyperpolarization. J Physiol (Lond) 1995;489:183-192
15. Maiello M, Boeri D, Podesta F, Cagliero E, Vichi M, Odetti P, et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cels cultured in elevated glucose. Diabetes 1992;41:1009-1015
16. Inoguchi T, Umeda F, Kunisaki M, Ishii H, Yamauchi T, Nawata H. Platelet stimulation for prostacyclin production in aortic endothelial cell cultures: Alteration in diabetes meilitus. Horm Metab Res 1991;23:539-544
17. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995;44:924-928
18. Geiger M, Binder BR. Plasminogen activation in diabetes mellitus: Kinetics of plasmin formation with plasminogen and tissue plasminogen activator from diabetic donors. Semin Thromb Hemost 1991;17:417-421
19. Bellart J, Gilabert R, Fontcuberta J, Miralles RM, Cabero L. Levels of coagulation inhibitors and thrombin-antithrombin III complexes in normal pregnancy. Med Sci Res 1997;25:699-702
20. Bellart J, Gilabert R, Fontcuberta J, Miralles RM, Cabero L. Fibrinolysis changes in normal pregnancy. J Perinatal Med 1997;25:368-372
21. Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol 1998;15: 81-85
22. Bellart J, Gilabert R, Miralles RM, Monasterio J, Cabero L. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gyn Obstet Invest 1998; 46:17-21
23. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057
24. Sowers JR, Tuck ML, Sowers DK. Plasma antithrombin III and thrombin generation time: Correlation with hemoglobin A1 and fasting serum glucose in young diabetic women. Diabetes Care 1980;3:655-658
25. Liu L, Dewar L, Song Y Kulczycky M, Blajchman MA, Fenton JW, et al. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Thromb Haemost 1995; 73:405-412
26. Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992;89:321-326
27. Bellart J, Gilabert R, Fontcuberta J, Borrell M, Miralles RM, Cabero L. Coagulation and fibrinolysis parameters in normal and in hypertensive pregnancies. Hypertension in pregnancy 1998;17:115-123
28. Bellart J, Gilabert R, Cabero L, Fontcuberta J, Monasterio J, Miralles RM. Heparin cofactor II: A new marker for pre-eclampsia. Blood Coag Fibrinol 1998;9:205-208
29. Zammit A, Dawes J. Fibrinogen inhibits the heparin cofactor II-mediated antithrombin activity of dermatan sulfate. Blood 1995;85:720-726
30. MacRury SM, Pinion S, Quin JD, O'Reilly DS, Lunan CB, Lowe GD, MacCuish AC. Blood rheology and albumin excretion in diabetic pregnancy. Diabetes Med 1995;12:51-55
31. Takahashi H, Ito S, Hanano M, Wada K, Niwano H, Seki Y, Shibata A. Circulating thrombomodulin as a novel endothelial cell marker: Comparision of its behaviour with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol 1992;41:32-39
32. Shirk RA, Church FC, Wagner WD. Arterial smooth muscle cell heparan sulfate protcoglycans accelerate thrombin inhibition by heparin cofactor II. Arterioscler Thromb Vasc Biol 1996;16:1138-1146